2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Nut and Peanut Hypersensitivity: new trials by email Literature Review of Nut and Peanut Hypersensitivity trials Research Report on Nut and Peanut Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy RPT904, Placebo - Immune System Diseases, Ig-E Mediated Food Allergy | Phase 2 | Active not recruiting | RAPT Therapeutics, Inc., a member of the GSK plc group of companies | 110 | 2025-12-15 | 2026-11-06 |
| A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy PVX-108, Placebo - Peanut Allergy, Peanut Hypersensitivity | Phase 2 | Active not recruiting | Aravax Pty Ltd | 95 | 2023-02-09 | 2026-11-02 |
Immune System Diseases (2) · Peanut Hypersensitivity (2) · Egg Hypersensitivity (1) · Milk Hypersensitivity (1)
Food Hypersensitivity (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2)
Aravax Pty Ltd (1) · RAPT Therapeutics, Inc., a member of the GSK plc group of companies (1)
Australia (2) · United States (2) · Canada (1)